Hi everybody,
regarding Ocrevus which we know is the marketing name for Ocrelizumab. The FDA have granted it breakthrough status and so it will be fast-tracked. Assuming they approve this drug will the EMA (Europoean authority) also grant approval automatically or will they then have to repeat the whole process, does anybody out there know?
Dave.